David Peloquin

Associate

david-peloquin
  • JD, Yale Law School, 2011; online editor, Yale Law Journal ; managing editor, Yale Journal on Regulation
  • BA (Economics), summa cum laude, Carleton College, 2006; Phi Beta Kappa

Qualifications

  • Massachusetts, 2011
  • New York, 2012
  • Honorable Diana E. Murphy, U.S. Court of Appeals for the Eighth Circuit
  • Community Member, Brigham & Women’s Hospital Institutional Review Board, Boston, MA

David Peloquin

Associate

David Peloquin joined the corporate department in 2012. He works primarily on health care matters, particularly in the area of clinical research and health data privacy. Prior to attending law school, David worked as a project manager for a leading supplier of electronic medical records.

Experience

  • Counsel multiple leading pediatric hospitals on matters related to “big data research collaborations”, receipt of research data from countries in the European Union, and design of biobanking research protocols and consent forms.
  • Counsel a leading information technology firm regarding compliant strategies for obtaining data from health care organizations.
  • Advised a university client in connection with a government investigation of its Select Agents research program.
  • Advised a university client regarding requirements for tissue donation consent forms under various state laws.
  • Assisted multiple clients in updating business associate agreements and research consent forms to comply with changes to HIPAA.
  • Assisted multiple clinical trial sponsors and sites in drafting informed consent forms and reviewing subject recruitment processes.
  • Advised a large pharmaceutical client regarding the permissibility of using clinical trials data and biospecimens for secondary research purposes.
  • Advised multiple clients regarding transfers of clinical trials data from the European Union to the United States. 
  • Analyzed for a pharmaceutical client the potential implications of changes to European Union privacy law on the conduct of clinical trials in Europe.
  • Analyzed for a major medical device company the pathway to seek reimbursement for its products in France, Germany and the United Kingdom.
  • Assisted multiple health care providers in preparing and submitting self-disclosures of overpayments to the Centers for Medicare and Medicaid Services, Medicare Administrative Contractors, and the New York Office of the Medicaid Inspector General.
  • Counseled hospital and clinical laboratory clients regarding the Medicare and New York Medicaid compliance implications of proposed billing practices.
  • Assisted a clinical laboratory client in identifying possible fraud and abuse violations and drafting internal policies related to fraud and abuse compliance.
  • Assisted a hospital client in filing administrative appeals of Medicare payment denials.

Publications

Presentations

  • Speaker, “Current Issues in Technology Transfer,” Ropes & Gray Roundtable (November 2, 2018) 
  • Association for the Accreditation of Human Research Protection Programs, Annual Conference, Presentation on Big Data & Confidentiality, Denver, CO (April 2018) 
  • Panelist, “The Importance of Data in Value-based Health Care,” Will Value-based Care Save the Health Care System? Conference at Harvard Law School Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics (March 2, 2018) 
  • Speaker, “Clinical Trials and Human Research: Complying With New Regulatory Obligations,” Strafford Webinar (January 17, 2018) 
  • Ropes & Gray Roundtable Discussion, “Complying With the EU GDPR Requirements in Clinical Trials” (December 2017)
  • Ropes & Gray Teleconference, “The EU GDPR: Implications for U.S. Academic Medical Centers Treating EU Patients and Conducting Other Activities in the EU” (November 2017)
  • Children’s Hospital Pediatric Research Alliance Conference, Presentation on Legal and Practical Considerations in the Sharing of Data and Biological Specimens for Research, Boston, MA (October 2017)
  • National Academies of Sciences, Engineering and Medicine, Panelist for Presentation on Laws and Regulations Governing the Return of Results to the Consensus Committee on the Return of Individual-Specific Research Results Generated in Research Laboratories, Washington, DC (September 2017)
  • International Association of Privacy Professionals, KnowledgeNet Presentation on Privacy and Research, Cambridge, MA (September 2017)
  • DIA, Clinical Trial Disclosure and Transparency Conference, Panelist for Discussion on Preparing for Results Submission Under the ClinicalTrials.gov Final Rule and Other Global Requirements, Rockville, MD (September 2017)
  • MAGI East Conference, “Recent Developments in Data Privacy and Security,” Philadelphia, PA (May 2017)
  • International Society for Biological and Environmental Repositories (ISBER), Annual Meeting, “Legal, Ethical and Structural Considerations in Biobanking Involving Academic and Commercial Entities,” Toronto, Canada (May 2017)
  • University of Connecticut, Annual Combined IRB Panel Meeting, talk entitled “Recent Developments in the Laws and Regulations Governing Human Subjects Research,” Farmington, CT (May 2017)
  • Jackson Heart Study, Workshop on Return of Results, University of Mississippi Medical Center, “Considerations for Institutional Review Boards,” Jackson, MS (April 2017)
  • Strafford Webinar:  “Complying With Final Rule Revising the Common Rule for Clinical Trials and Human Research” (February 2017)
  • Strafford Publications, webinar entitled “Clinical Trials and Human Research: Complying with New Regulatory Obligations” (January 2017)
  • Children’s Hospitals Pediatric Research Alliance Conference, presentation entitled “Consortium Collaborations: Contractual Considerations,” Philadelphia, PA (November 2016)
  • MAGI West Conference, presentation entitled “Recent Developments in Research Subject Data Privacy,” Las Vegas, NV (October 2016)
  • Biorepositories & Sample Management Conference, presentation entitled “Impact of Changes in European Union Data Privacy Law on Biorepositories,” Boston, MA (October 2016)
  • American Health Lawyers Association, Academic Medical Center & Teaching Hospitals Conference, presentation entitled “Hot Topics in Genomics Care and Research,” Washington, DC (March 2016)
  • Petrie-Flom Center, Harvard University, Specimen Science Conference, presentation entitled “Legal and Regulatory Issues in Biospecimen Research: National and International Perspectives,” Cambridge, MA (November 2015)
  • American Society for Bioethics and Humanities, Annual Meeting, presentation entitled “Engaged in the Conduct of Research? How to Keep the Government from Finding Violations and What to do When They Do,” Houston, TX (October 2015) 
Cookie Settings